Malaria drug has no benefit for Covid-19 patients, but higher death rate: study

Published April 22, 2020
Hydroxychloroquine and a related compound chloroquine have been used for decades to treat malaria, as well as autoimmune disorders lupus and rheumatoid arthritis. — AFP
Hydroxychloroquine and a related compound chloroquine have been used for decades to treat malaria, as well as autoimmune disorders lupus and rheumatoid arthritis. — AFP

A malaria drug widely touted as a potential cure for Covid-19 showed no benefit against the disease over standard care — and was in fact associated with more deaths, the biggest study of its kind showed on Tuesday.

The US government-funded analysis of how American military veterans fared on hydroxychloroquine was posted on a medical preprint site and has not yet been peer reviewed.

The experiment had several important limitations, but adds to a growing body of doubt over the efficacy of the medicine that counts US President Donald Trump and right-wing news channel Fox News among its biggest backers.

Researchers looked at the medical records of 368 veterans hospitalised in US who either died or were discharged by April 11.

Death rates for patients on hydroxychloroquine were 28 per cent, compared to 22pc when it was taken with the anti-biotic azithromycin — a combination favoured by French scientist Didier Raoult, whose study on the subject in March triggered a surge of global interest in the drug.

The death rate for those receiving only standard care was 11pc.

Hydroxychloroquine, with or without azithromycin, was more likely to be prescribed to patients with more severe illness, but the authors found that increased mortality persisted even after they statistically adjusted for higher rates of use.

Other drawbacks include the fact that the study did not assign people randomly to groups, because it was a retrospective analysis meaning it looked back on what had already happened.

In addition, the results are hard to generalise because the population was highly specific — most of the patients were male, with a median age over 65, and black, a group that is disproportionately affected by underlying illnesses such as diabetes and heart disease.

There was no added risk of being on ventilator among the hydroxychloroquine-only group, leading the authors to suggest that increased mortality among this group might be attributable to side-effects outside the respiratory system.

Previous research has found that the medicine is risky for patients with certain heart rhythm issues and can cause blackouts, seizures or at times cardiac arrest in this group.

Hydroxychloroquine and a related compound chloroquine have been used for decades to treat malaria, as well as the autoimmune disorders lupus and rheumatoid arthritis.

They have received significant attention during the novel coronavirus pandemic and have been shown in lab settings to block the virus from entering cells and prevent it replicating — but in the pharmaceutical world, "in vitro" promise often fails to translate into "in vivo" success.

The true answer can only be determined through very large, randomised clinical trials that assign patients to receive either the drug under investigation or a placebo.

Several of these are underway, including notably in the United States, Europe, Canada and the United Kingdom.

Opinion

Educating merged districts
Updated 12 Apr 2021

Educating merged districts

The seven merged districts of KP, with a combined population of over five million, do not have a single university.
Greater visibility
12 Apr 2021

Greater visibility

It is not surprising that the custodians of patriarchy are fearful.
Rethinking executions
11 Apr 2021

Rethinking executions

One convict’s fight to escape the gallows exposes the deep flaws in our criminal justice system.

Editorial

Pakistan-India peace
Updated 12 Apr 2021

Pakistan-India peace

Experts note that everything — including Kashmir — can be resolved if there is a will in both capitals.
12 Apr 2021

Child abuse

IN its annual report, the NGO Sahil found that there has been a 4pc increase in documented cases of major crimes...
12 Apr 2021

New tax chief’s task

THE FBR got a new chairman on Friday. Asim Ahmed, a senior IRS officer who was serving as the Board’s IT member...
11 Apr 2021

Dissension within PTI

WITH the dust from the PDM’s implosion still not fully settled, the PTI is now faced with growing dissension from...
11 Apr 2021

Power to arrest

A SUPREME Court verdict announced on Thursday spelled out what might be considered a self-evident truth in any...
11 Apr 2021

Unequal vaccine distribution

IT is in times of crisis that we often see the best — or worst — of humanity. In this regard, the pandemic has...